Rituximab (anti-CD20 monoclonal antibody) administration in a young patient with resistant B-prolymphocytic leukemia

dc.contributor.authorVartholomatos, G.en
dc.contributor.authorTsiara, S.en
dc.contributor.authorChristou, L.en
dc.contributor.authorPanteli, A.en
dc.contributor.authorKaiafas, P.en
dc.contributor.authorBourantas, K. L.en
dc.date.accessioned2015-11-24T18:53:19Z
dc.date.available2015-11-24T18:53:19Z
dc.identifier.issn0001-5792-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/18538
dc.rightsDefault Licence-
dc.subjectAdulten
dc.subjectAntibodies, Monoclonal/*therapeutic useen
dc.subjectAntibodies, Monoclonal, Murine-Deriveden
dc.subjectAntineoplastic Agents/*therapeutic useen
dc.subject*Drug Resistance, Multipleen
dc.subject*Drug Resistance, Neoplasmen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectLeukemia, B-Cell/*drug therapyen
dc.subjectLeukemia, Promyelocytic, Acute/*drug therapyen
dc.titleRituximab (anti-CD20 monoclonal antibody) administration in a young patient with resistant B-prolymphocytic leukemiaen
heal.abstractFollowing the administration of the human anti-CD20 monoclonal antibody IDEC-C2B8 (rituximab), a 31-year-old woman with B-prolymphocytic leukemia, who had been resistant to CHOP, fludarabine, pentostatin and 2-CdA, achieved complete remission. Rituximab was administered intravenously once a week for 4 weeks. The patient only had mild but tolerable side effects during the first cycle of therapy. She remains in complete remission 8 months following the discontinuation of treatment.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/10529513-
heal.identifier.secondaryhttp://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000040977-
heal.journalNameActa Haematolen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate1999-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: